|
N'-[(E)-(2,4-dihydroxyphenyl)methylidene]-4-nitrobenzohydrazide |
|
Escherichia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Tree JJ, et al. 2009. Infect Immun; Wang D, et al. 2011. J Biol Chem |
|
N-[3-(2-amino-1H-imidazol-5-yl)phenyl]-4-pentylbenzamide;hydrochloride |
Depiction based on curated SMILES
HN
ClH
H
2
N
N
H
N
H
3
C
O
|
Escherichia |
Biofilm |
Preclinical (in vitro) |
Bunders CA, et al. 2010. Bioorg Med Chem Lett |
|
N-[4-(2-amino-1H-imidazol-5-yl)phenyl]-3,5-difluorobenzamide;hydrochloride |
Depiction based on curated SMILES
N
H
ClH
F
F
O
H
2
N
N
H
N
|
Escherichia Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Bunders CA, et al. 2010. Bioorg Med Chem Lett
|
|
N-[4-(2-amino-1H-imidazol-5-yl)phenyl]-4-pentylbenzamide;hydrochloride |
Depiction based on curated SMILES
N
H
ClH
H
2
N
N
H
N
CH
3
O
|
Escherichia |
Biofilm |
Preclinical (in vitro) |
Bunders CA, et al. 2010. Bioorg Med Chem Lett |
|
N-[4-(2-amino-1H-imidazol-5-yl)phenyl]-3,5-dichlorobenzamide |
Depiction based on curated SMILES
NH
2
Cl
Cl
O
N
H
N
H
N
|
Francisella |
Regulation |
Preclinical (in vitro) |
Milton ME, et al. 2017. Mol Microbiol |
|
(4Z)-2-benzyl-4-[(3-bromo-4-methoxyphenyl)methylidene]-5-(trifluoromethyl)pyrazol-3-one |
Depiction based on curated SMILES
Br
F
F
F
O
H
3
C
N
N
O
|
Haemophilus |
LOS |
Preclinical (in vitro) |
Xu Y, et al. 2018. Bioorg Med Chem |
|
1-Phenyl-3-(trifluoromethyl)-4-[(Z)-3-(benzyloxy)benzylidene]-2-pyrazoline-5-one |
Depiction based on curated SMILES
F
F
F
O
N
N
O
|
Haemophilus |
LOS |
Preclinical (in vitro) |
Xu Y, et al. 2018. Bioorg Med Chem |
|
1-Phenyl-3-(trifluoromethyl)-4-[(Z)-3-bromo-4-methoxybenzylidene]-2-pyrazoline-5-one |
Depiction based on curated SMILES
Br
F
F
F
O
H
3
C
N
N
O
|
Haemophilus |
LOS |
Preclinical (in vitro) |
Xu Y, et al. 2018. Bioorg Med Chem |
|
(4Z)-4-[(4-chlorophenyl)methylidene]-2-phenyl-5-(trifluoromethyl)pyrazol-3-one |
Depiction based on curated SMILES
F
F
F
N
Cl
O
N
|
Haemophilus |
LOS |
Preclinical (in vitro) |
Xu Y, et al. 2018. Bioorg Med Chem |
|
3-[(4Z)-4-[(3-bromo-4-methoxyphenyl)methylidene]-5-oxo-3-(trifluoromethyl)pyrazol-1-yl]-N-(2-hydroxyethyl)benzamide |
Depiction based on curated SMILES
Br
F
F
F
OH
NH
O
CH
3
O
N
N
O
|
Haemophilus |
LOS |
Preclinical (in vitro) |
Xu Y, et al. 2018. Bioorg Med Chem |
|
| | |